B BRAUN MEDICAL INC vs Hikma Pharmaceuticals USA INC: FDA Enforcement Comparison

B BRAUN MEDICAL INC has been the subject of 22 FDA enforcement/approval records tracked by Argus HQ, compared to 2 for Hikma Pharmaceuticals USA INC.

B BRAUN MEDICAL INC: 0 warning letters, 22 recalls, 0 approval records, 0 Form 483s.

Hikma Pharmaceuticals USA INC: 0 warning letters, 1 recall, 1 approval record, 0 Form 483s.

Side by side

B BRAUN MEDICAL INC — Warning letters0

Hikma Pharmaceuticals USA INC — Warning letters0

B BRAUN MEDICAL INC — Recalls22

Hikma Pharmaceuticals USA INC — Recalls1

B BRAUN MEDICAL INC — Approval records0

Hikma Pharmaceuticals USA INC — Approval records1

B BRAUN MEDICAL INC — Form 483s0

Hikma Pharmaceuticals USA INC — Form 483s0

Timeline

B BRAUN MEDICAL INC

Most recent FDA action: June 10, 2026

Full history →

Hikma Pharmaceuticals USA INC

Most recent FDA action: June 17, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"B BRAUN MEDICAL INC vs Hikma Pharmaceuticals USA INC: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/b-braun-medical-inc-vs-hikma-pharmaceuticals-usa-inc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗